Skip to main content

Table 1 Genotypes and antibiotic susceptibility patterns of CA- & HA-MRSA from children ≤5 years in eastern Uganda

From: CA-MRSA and HA-MRSA coexist in community and hospital settings in Uganda

Isolate # PVL mecA SCCmec FOX PEN TET ERY SXT CHL GEN CIP CLI RIF VAN LZD MDR phenotype Spa type
HA-MRSA (n = 21)
 52–1 + + I R R R R R R R S S S S S Yes  
 1320–1 + I R R R R R R R R S S S S Yes  
 244C-1 + I R R R R R R R S S S S S Yes  
 K1057–1 + I R R R S S R R S S S S S Yes t037
 K264–1 + + I R R R S S R R S S S S S Yes  
 K284–1 + I R R R R R R R S S S S S Yes  
 K36–1 + I R R R R R R S S S S S S Yes t037
 K370–1 + I R R R R R R R S S S S S Yes  
 K39–1 + I R R R R R R R R S S S S Yes  
 K4834–1 + I R R R S S R R S S S S S Yes t037
 K970–1 + I R R R S I S S I S S S S No t037
 R030–1 + I R R R R R R R R S S S S Yes  
 R10–1 + I R R R R R R S R S S S S Yes t12939
 R110–1 + + I R R R R R S S S S S S S Yes Unknown
 R19–1 + I R R R R R R R S S S S S Yes  
 R220–1 + I R R R R R S R S S S S S Yes Unknown
 1322–1 + + II R R R R R R R I I S S S Yes  
 306C-1 + II R R R R R I R S S S S S Yes  
 K911–1 + II R R R R S R R R S S S S Yes  
 R160–1 + II R R R R R S S S S S S S Yes t002
 R17–1 + III R R R S R S I S S S S S Yes t037
 Total +/R HA-MRSA (%) 4 (19) 21 (100) 21 (100) 21 (100) 21 (100) 21 (100) 16 (76.2) 16 (76.2) 15 (71.4) 15 (71.4) 5 (23.8) 0 (0) 0 (0) 0 (0) 0 (0) 20 (95.2)  
CA-MRSA (n = 21)
 1325–1 + IV R R R R R R I S S S S S Yes Unknown
 1326–1 + + IV R R R R S S S R S S S S Yes  
 K2240–1 + IV R R S S S S S R I S S S No t4353
 K2810–1 + IV R R R R R S S R S S S S Yes  
 R31B-1 + IV R R R R R S R R S S S S Yes t064
 R310–1 + IV R R R R R R R S S S S S Yes t064
 R33–1 + + IV R R R R R R R S S S S S Yes t064
 K3700–1 + IV R R R S S R R S S S S S Yes  
 R0100–1 + IV R R R R R S S S S S S S Yes t064
 R02–1 + IV R R R R R R S R S S S S Yes Unknown
 R020–1 + IV R R S S R R R S S S S S Yes  
 R0300–1 + IV R R R R R R S S S S S S Yes  
 R06–1 + IV R R R R R S R S S S S S Yes t064
 R08–1 + + IV R R R R R R R S S S S S Yes t064
 R18–1 + IV R R R R S R S R S S S S Yes  
 R20–1 + IV R R I R R R R S S S S S Yes t064
 R26A-1 + IV R R R R R S S R S S S S Yes t064
 R040–1 + V R R R R R R R R S S S S Yes  
 K60–1 + + V R R R R R S S R S S S S Yes  
 K38–1 + V R R R R R R R I S S S S Yes  
 K350C-1 + + V R R R S S S S R S S S S Yes Unknown
 Total +/R CA-MRSA (%) 5 (24) 21 (100) 21 (100) 21 (100) 21 (100) 18 (85.7) 17 (81) 16 (76.2) 12 (57.1) 10 (47.6) 10 (47.6) 0 (0) 0 (0) 0 (0) 0 (0) 20 (95.2)  
Grand Total +/R (%) 9 (21.4) 42 (100) 42 (100) 42 (100) 42 (100) 39 (92.9) 33 (78.6) 32 (76.2) 27 (64.3) 25 (59.5) 15 (35.7) 0 (0) 0 (0) 0 (0) 0 (0) 40/42 (95.2)  
  1. The most prevalent Spa types are presented in boldface font
  2. FOX cefoxitin, PEN penicillin, TET tetracycline, SXT, ERY erythromycin, CHL chloramphenicol, GEN gentamycin, CIP ciprofloxacin, CLI clindamycin, RIF rifampicin, VAN vancomycin, LZD linezolid, MDR multidrug resistant –resistance to three or more classes of antimicrobials; + Positive, − Negative